Lawrence Corey

Co-Founder & Scientific Advisor, VIR BIOTECHNOLOGY INC

Search every verified Lawrence Corey interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Lawrence Corey, co-founder and scientific advisor at Vir Biotechnology, discussed COVID-19 vaccine development in a May 2020 podcast appearance. He stated that the need to vaccinate the entire globe requires parallel development of multiple vaccines, emphasizing that scaling and manufacturing are critical to reducing the time from testing to distribution. He also said that a vaccine efficacy of 60 to 70 percent in decreasing COVID-19 disease would be "terrific" and would markedly reduce morbidity and mortality, while noting that 90 percent efficacy would be "really great." Corey also reflected on his career in HIV vaccine research, expressing optimism that the COVID-19 vaccine effort would be easier than the decades-long HIV vaccine quest. He noted that science has provided a good target for COVID-19 and that he hoped a rapid assessment would succeed without needing to resort to alternative plans.